Your browser doesn't support javascript.
loading
Surgical aortic valve replacement with new-generation bioprostheses: Sutureless versus rapid-deployment.
D'Onofrio, Augusto; Salizzoni, Stefano; Filippini, Claudia; Tessari, Chiara; Bagozzi, Lorenzo; Messina, Antonio; Troise, Giovanni; Tomba, Margerita Dalla; Rambaldini, Manfredo; Dalén, Magnus; Alamanni, Francesco; Massetti, Massimo; Mignosa, Carmelo; Russo, Claudio; Salvador, Loris; Di Bartolomeo, Roberto; Maselli, Daniele; De Paulis, Ruggero; Alfieri, Ottavio; De Filippo, Carlo Maria; Portoghese, Michele; Bortolotti, Uberto; Rinaldi, Mauro; Gerosa, Gino.
Afiliação
  • D'Onofrio A; Division of Cardiac Surgery, Azienda Ospedaliera/University of Padua, Padua, Italy. Electronic address: adonofrio@hotmail.it.
  • Salizzoni S; Division of Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy.
  • Filippini C; Division of Cardiac Surgery, University of Turin, Turin, Italy.
  • Tessari C; Division of Cardiac Surgery, Azienda Ospedaliera/University of Padua, Padua, Italy.
  • Bagozzi L; Division of Cardiac Surgery, Azienda Ospedaliera/University of Padua, Padua, Italy.
  • Messina A; Division of Cardiac Surgery, Poliambulanza Foundation, Brescia, Italy.
  • Troise G; Division of Cardiac Surgery, Poliambulanza Foundation, Brescia, Italy.
  • Tomba MD; Division of Cardiac Surgery, Poliambulanza Foundation, Brescia, Italy.
  • Rambaldini M; Division of Cardiac Surgery, C. Poma Hospital, ASST Mantua, Mantua, Italy.
  • Dalén M; Division of Cardiac Surgery, Karolinska Institute, Solna, Sweden.
  • Alamanni F; Division of Cardiac Surgery, Monzino Hospital, Milan, Italy.
  • Massetti M; Division of Cardiac Surgery, Gemelli Hospital, Catholic University, Rome, Italy.
  • Mignosa C; Division of Cardiac Surgery, Morgagni Hospital, Catania, Italy.
  • Russo C; Division of Cardiac Surgery, Sacco Hospital, Milan, Italy.
  • Salvador L; Division of Cardiac Surgery, S. Bortolo Hospital, Vicenza, Italy.
  • Di Bartolomeo R; Division of Cardiac Surgery, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Maselli D; Division of Cardiac Surgery, S. Anna Hospital, Catanzaro, Italy.
  • De Paulis R; Division of Cardiac Surgery, European Hospital, Rome, Italy.
  • Alfieri O; Division of Cardiac Surgery, S. Raffaele Hospital, Milan, Italy.
  • De Filippo CM; Division of Cardiac Surgery, Fondazione Giovanni Paolo II, Campobasso, Italy.
  • Portoghese M; Division of Cardiac Surgery, ASSL Sassari, Sassari, Italy.
  • Bortolotti U; Division of Cardiac Surgery, University of Pisa, Pisa, Italy.
  • Rinaldi M; Division of Cardiac Surgery, Molinette Hospital, University of Turin, Turin, Italy.
  • Gerosa G; Division of Cardiac Surgery, Azienda Ospedaliera/University of Padua, Padua, Italy.
J Thorac Cardiovasc Surg ; 159(2): 432-442.e1, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31213376
OBJECTIVES: The aim of this retrospective multicenter study was to compare early clinical and hemodynamic outcomes of Perceval-S sutureless (Livanova, London, United Kingdom) and Intuity rapid-deployment (Edwards Lifesciences, Irvine, Calif) bioprostheses. METHODS: Data from patients who underwent isolated or combined aortic valve replacement with Perceval-S and with Intuity bioprostheses at 18 cardiac surgical institutions were analyzed. Propensity matching was performed to identify similar patient cohorts. RESULTS: We included 911 patients from March 2011 until May 2017. Perceval-S and Intuity valves were implanted in 349 (38.3%) and in 562 (61.7%) patients, respectively. Propensity score identified 117 matched pairs. In the matched cohort, device success was 99.1% and 100% in Perceval-S and Intuity group, respectively (P = 1.000). Thirty-day Valve Academic Research Consortium mortality occurred in 2 (1.7%) and 4 (3.4%) patients in the Perceval-S and in Intuity group, respectively (P = .6834). The rate of postoperative new permanent pacemaker implantation was 6% (7 patients) and 6.8% (8 patients) in the Perceval-S and in Intuity group, respectively (P = .7896). Perceval-S valve implantation requires significantly shorter aortic crossclamp and cardiopulmonary bypass times than Intuity valve implantation (aortic crossclamp time for isolated, 52 ± 14 minutes vs 62 ± 24 minutes; P < .0001). Peak transaortic gradients were 22.4 ± 8.1 mm Hg and 19.6 ± 6.7 mm Hg (P = .0144), whereas mean gradients were 11.8 ± 4.7 mm Hg and 10.5 ± 3.9 mm Hg (P = .0388) in the Perceval-S and Intuity groups, respectively. CONCLUSIONS: Sutureless Perceval-S and rapid-deployment Intuity bioprostheses provide good and similar early clinical and hemodynamic outcomes. Perceval-S valve implantation requires shorter crossclamp and cardiopulmonary bypass times, whereas Intuity valve implantation provides lower transaortic peak and mean gradients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valva Aórtica / Bioprótese / Próteses Valvulares Cardíacas / Implante de Prótese de Valva Cardíaca / Procedimentos Cirúrgicos sem Sutura Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valva Aórtica / Bioprótese / Próteses Valvulares Cardíacas / Implante de Prótese de Valva Cardíaca / Procedimentos Cirúrgicos sem Sutura Idioma: En Ano de publicação: 2020 Tipo de documento: Article